Evaluation of Health-Related Quality of Life in Hemolytic Uraemic Syndrome Patients Treated With Eculizumab: A Systematic Evaluation on Basis of EMPRO
Renal Failure - United States
doi 10.1080/0886022x.2018.1427110
Full Text
Open PDFAbstract
Available in full text
Date
January 24, 2018
Authors
Publisher
Informa UK Limited